On Ordering the Previous Question: HRES 787
Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.
House Roll Call #117 • 115th Congress
About 787
Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.
See sponsors, cosponsors, summary, and legislative timeline
Vote by Party
Democrats (0)
Republicans (0)
Independents (0)
Individual Member Votes Loading
House Roll Call: Individual member positions are being processed from official XML data.
The vote totals shown above reflect the final counts. Individual representative positions will be displayed once the XML parsing is complete. This process may take a few moments for House votes with 435 members.
Data source: congress-api•Processed: 10/3/2026•Confidence: high